Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 50013696
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568672(CHEMBL4863234)
Affinity DataIC50: 17nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568670(CHEMBL4849790)
Affinity DataIC50: 46nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568675(CHEMBL4863569)
Affinity DataIC50: 100nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568674(CHEMBL4873341)
Affinity DataIC50: 100nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568661(CHEMBL4863990)
Affinity DataIC50: 120nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568673(CHEMBL4876176)
Affinity DataIC50: 130nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50333241(N-(4-chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidi...)
Affinity DataIC50: 170nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568663(CHEMBL4859187)
Affinity DataIC50: 230nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568669(CHEMBL4853102)
Affinity DataIC50: 250nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568662(CHEMBL4859112)
Affinity DataIC50: 290nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568664(CHEMBL4846044)
Affinity DataIC50: 330nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568665(CHEMBL4875361)
Affinity DataIC50: 420nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568668(CHEMBL4871020)
Affinity DataIC50: 570nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568660(CHEMBL4873137)
Affinity DataIC50: 720nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568666(CHEMBL4878723)
Affinity DataIC50: 880nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568671(CHEMBL4878191)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568661(CHEMBL4863990)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568665(CHEMBL4875361)
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568667(CHEMBL4872281)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of HIV1 KP-5mvcR gp120 interaction with CD4 in human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568662(CHEMBL4859112)
Affinity DataIC50: 3.90E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568663(CHEMBL4859187)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568666(CHEMBL4878723)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50333241(N-(4-chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidi...)
Affinity DataIC50: 6.90E+3nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568664(CHEMBL4846044)
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568660(CHEMBL4873137)
Affinity DataIC50: 4.30E+4nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Tokyo Medical and Dental University (Tmdu)

Curated by ChEMBL
LigandPNGBDBM50568676(CHEMBL4851608)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HIV1 KP-5mp1 gp120 interaction with CD4 human TZM-bl cells assessed as decrease in viral entry by MTT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed